Evidence map›Paper›PMID 42379735›Full record

ArticleIn vivo (Athens, Greece)

Development of a Plasma Spot Assay for Detection of Fluorophore-labeled Antibodies in Mouse Imaging Studies.

Norman C Peterson, Teri L Blevins, David J Ortiz

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Norman C PetersonDrug Safety Research & Development, Pfizer, Inc., Bothell, WA, U.S.A.; ncpdvmphd@gmail.com.
Teri L BlevinsDrug Safety Research & Development, Pfizer, Inc., Bothell, WA, U.S.A.
David J OrtizPharmacokinetics, Dynamics, and Metabolism, Pfizer, Inc., Bothell, WA, U.S.A. david.ortiz3@pfizer.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimMATERIALS AND

methodsWe developed a fluorescent plasma spot assay (FPSA) to measure relative Ab-F fluorescence in plasma and enable standardization of tissue fluorescence obtained during optical imaging studies.

resultsFPSA measurements were consistent with Ab-F concentration and degree-of-labeling data generated by conventional analytical methods, including immunoassay and spectrophotometry. Additionally, the FPSA was used to determine fluorophore type and DOL conditions with minimal effects on Ab-F clearance and tissue retention to minimize in-study artifacts.

conclusionThe FPSA can be performed concurrently with

Indexed as

AntibodiesAntibodies, MonoclonalFluorescent DyesImmunoconjugatesOptical ImagingAnimalsHumansMiceTissue DistributionAntibodiesAntibodies, MonoclonalFluorescent DyesImmunoconjugatesantibody drug conjugate (ADC)Biodistributionbiotherapeuticscancerin vivo imagingnear-infrared fluorescenceoptical imagingpharmacokinetics

Identifiers

PMID42379735
PMCPMC13322060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.